Ispire Technology Inc Stock Soars on Trading Day

Business by 2FIRSTS.ai
Dec.11.2023
Ispire Technology Inc Stock Soars on Trading Day
Ispire Technology's stock rose 4.8% during Thursday's trading, reaching a high of $11.70 before closing at $11.45.

According to a report from Riverton Roll, shares of Ispire Technology Inc (NASDAQ: ISPR) witnessed a 4.8% rise during trading on Thursday, December 7. The stock reached its peak at $11.70, eventually closing at $11.45.

 

During the trading period, a total of 39,386 shares were traded, which is a decrease of 46% from the average daily trading volume of 73,106 shares. The closing price of this stock the previous day was $10.93.

 

Ispire is a company that specializes in the research, development, design, commercialization, sales, marketing, and global distribution of e-cigarette and cannabis e-cigarette products. The company was established in 2019 and is headquartered in Los Angeles, California. Operating as a subsidiary of Pride Worldwide Investment Limited, Ispire aims to provide innovative vaping solutions to customers worldwide.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds
62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds
Vape retailer Haypp reports that 62.5% of vapers still use disposable vapes, rising to 82% among those aged 25–34. 35% of disposable users say they are still buying disposables. Black-market purchases reportedly come mainly from local smaller shops (55%) and specialist vape stores (37%), as well as supermarkets, online retailers and car boot sales. 78.5% of respondents are using pre-ban stock, posing safety risks from aging lithium-ion batteries; 14% plan to continue buying disposables,.
Oct.23 by 2FIRSTS.ai
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai
BAT Japan to raise prices of glo heated-tobacco sticks by about 4%–5%
BAT Japan to raise prices of glo heated-tobacco sticks by about 4%–5%
BAT Japan said it will raise retail prices by ¥20 (about $0.13) per pack for 16 glo heated-tobacco stick brands—11 Lucky Strike and five Kent—effective January 1, 2026. The company will also lift prices for 12 VELO nicotine pouch brands by ¥20–¥40 per pack from December 1, 2025.
Oct.21 by 2FIRSTS.ai
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
As reduced-risk products emerge as the industry’s inevitable future, the question of how to transition has become a defining challenge for tobacco companies. In recent years, JTI has continued to invest in the combustible segment while gradually advancing its next-generation products — a path distinct from that of PMI and BAT, yet one that offers valuable insights for other legacy tobacco companies around the world.
Sep.29
2Firsts Observation | U.S. E-cigarette Regulation Enters Normalized Phase as Federal and State Authorities Tighten Compliance Frameworks
2Firsts Observation | U.S. E-cigarette Regulation Enters Normalized Phase as Federal and State Authorities Tighten Compliance Frameworks
In just two months, U.S. authorities seized over 7 million illegal e-cigarettes. 2Firsts’ analysis reveals a shift toward institutionalized regulation, with federal and state agencies intensifying enforcement — signaling a major reset in the world’s largest and most influential vaping market.
Oct.28
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04